Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Withdrawn 1Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Glioblastoma 44Glioma 16Melanoma 11Central Nervous System Neoplasms 11Astrocytoma 11Brain Neoplasms 10Oligodendroglioma 7Gliosarcoma 5Small Cell Lung Carcinoma 4Recurrence 3Lymphoma 3Leiomyosarcoma 3Sarcoma 2Neoplasms, Neuroepithelial 2Neoplasms 2Neoplasm Metastasis 2Ependymoma 2Diffuse Intrinsic Pontine Glioma 2Breast Neoplasms 2Uveal Melanoma 1Seizures 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma, Endometrial Stromal 1Sarcoma, Alveolar Soft Part 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Recurrent Extensive Stage Small Cell Lung Carcinoma 1Rectal Neoplasms 1Pituitary Neoplasms 1

Interventions

Dexmedetomidine 3Saline Solution 2Hydrocortisone 2parecoxib 1loxoprofen 1lanreotide 1Visual Field Tests 1Visual Acuity 1Transcranial Magnetic Stimulation 1Tramadol 1Temozolomide 1TBR-760 1Surgical Procedures, Operative 1Solutions 1Sodium Chloride 1Sevoflurane 1Rosiglitazone 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy 1Radiosurgery 1Propofol 1Prednisone 1Positron-Emission Tomography 1Nasal Lavage 1Magnetic Resonance Spectroscopy 1Injections 1Fluorodeoxyglucose F18 1Early Intervention, Educational 1Diffusion Tensor Imaging 1Desflurane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Pituitary Neoplasms × Temozolomide × Clear all
NCT04244708 2020-01-28

The Effect of Chemoradiotherapy in Patients With Refractory Pituitary Adenomas

Peking Union Medical College Hospital

Phase 2/3 Unknown
150 enrolled
Endocrine

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡